HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Piero Pollesello Selected Research

Cardio-Renal Syndrome

4/2021An update on levosimendan in acute cardiac care: applications and recommendations for optimal efficacy and safety.
1/2019Use of Levosimendan in Intensive Care Unit Settings: An Opinion Paper.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Piero Pollesello Research Topics

Disease

40Heart Failure
01/2022 - 11/2002
6Ischemia
01/2016 - 09/2004
5Myocardial Ischemia (Ischemic Heart Diseases)
12/2012 - 12/2004
4Cardiogenic Shock
04/2021 - 01/2020
4Reperfusion Injury
01/2015 - 09/2007
3Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
03/2020 - 11/2019
3Pulmonary Hypertension
03/2020 - 12/2004
3Low Cardiac Output
01/2020 - 11/2016
3Myocardial Infarction
07/2016 - 09/2004
3Wounds and Injuries (Trauma)
01/2015 - 08/2012
2Cardio-Renal Syndrome
04/2021 - 01/2019
2Takotsubo Cardiomyopathy
03/2020 - 01/2020
2Septic Shock (Toxic Shock Syndrome)
01/2019 - 04/2009
2Fibrosis (Cirrhosis)
01/2019 - 01/2015
2Hypotension (Low Blood Pressure)
09/2016 - 09/2014
1Hypovolemia
04/2021
1Cardiomyopathies (Cardiomyopathy)
04/2021
1Hypokalemia
04/2021
1Heart Diseases (Heart Disease)
03/2020
1Hypertrophy
12/2019
1Paralysis (Palsy)
11/2019
1Inflammation (Inflammations)
10/2019
1Infections
10/2019
1Necrosis
10/2019
1Critical Illness (Critically Ill)
01/2019
1Coronary Vasospasm (Coronary Artery Vasospasm)
01/2019
1Fatigue
12/2018
1Acute Coronary Syndrome
09/2016
1Heart Arrest (Cardiac Arrest)
07/2016
1Oliguria
07/2016
1Myocardial Stunning (Stunned Myocardium)
03/2016
1Ventricular Tachycardia
01/2016
1Cardiac Arrhythmias (Arrythmia)
01/2016
1Ventricular Premature Complexes (Premature Ventricular Contraction)
01/2016
1Stroke (Strokes)
03/2015
1Shock
09/2014
1B-Cell Lymphoma (Lymphoma, B Cell)
03/2014

Drug/Important Bio-Agent (IBA)

39Simendan (Levosimendan)IBA
01/2022 - 09/2004
11CalciumIBA
02/2021 - 11/2004
9Pharmaceutical PreparationsIBA
04/2021 - 09/2004
7Adenosine Triphosphate (ATP)IBA
01/2015 - 09/2004
4DobutamineFDA LinkGeneric
04/2021 - 12/2012
4Vasodilator Agents (Vasodilators)IBA
12/2019 - 03/2012
4Potassium Channels (Potassium Channel)IBA
12/2018 - 12/2004
3Milrinone (Primacor)FDA LinkGeneric
04/2021 - 06/2006
3Brain Natriuretic Peptide (Natrecor)FDA Link
12/2019 - 09/2017
2AntioxidantsIBA
01/2020 - 08/2012
2Thiobarbituric Acid Reactive SubstancesIBA
01/2020 - 03/2014
2Glutathione (Reduced Glutathione)IBA
01/2020 - 03/2014
2DiureticsIBA
12/2019 - 09/2014
2ORM-3819IBA
01/2019 - 03/2016
2Biomarkers (Surrogate Marker)IBA
01/2019 - 12/2012
2Phosphodiesterase InhibitorsIBA
12/2016 - 06/2006
2Vasoconstrictor AgentsIBA
09/2016 - 05/2006
2Glucose (Dextrose)FDA LinkGeneric
07/2016 - 05/2004
2mitochondrial K(ATP) channelIBA
01/2015 - 09/2007
2Proteins (Proteins, Gene)FDA Link
03/2014 - 04/2013
2phospholambanIBA
04/2013 - 11/2002
2PotassiumIBA
09/2007 - 09/2004
2Troponin CIBA
01/2005 - 11/2004
1Natriuretic PeptidesIBA
02/2021
1Oxidants (Oxidizing Agents)IBA
01/2020
1Adrenergic beta-Agonists (beta-Adrenergic Agonists)IBA
12/2019
1Dopamine (Intropin)FDA LinkGeneric
12/2019
1Norepinephrine (Noradrenaline)FDA LinkGeneric
12/2019
1Type 3 Cyclic Nucleotide PhosphodiesterasesIBA
12/2019
1CatecholaminesIBA
12/2019
1Epinephrine (Adrenaline)FDA LinkGeneric
12/2019
1UlaritideIBA
11/2019
1Cardiovascular AgentsIBA
11/2019
1Reactive Nitrogen SpeciesIBA
10/2019
1LipopolysaccharidesIBA
10/2019
1Interleukin-6 (Interleukin 6)IBA
10/2019
1Toll-Like Receptor 4IBA
10/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2019
1Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA
01/2019
1Oxygen (Dioxygen)IBA
12/2018
1LiraglutideFDA Link
09/2017
1Adrenergic Agonists (Adrenergic Receptor Agonist)IBA
12/2016
1TransferasesIBA
07/2016
1CreatinineIBA
07/2016
1Alanine (L-Alanine)FDA Link
07/2016
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
07/2016
1ORM-10962IBA
01/2016
1Sodium-Calcium ExchangerIBA
01/2016
1Ouabain (G Strophanthin)IBA
01/2016
1Valsartan (Vals)FDA Link
03/2015
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2015
1NAD (NADH)IBA
10/2014
15- nitro- 2- (2- phenylchroman- 6- yloxy)pyridineIBA
10/2014
1Caspase 9IBA
03/2014
1Transaminases (Aminotransferases)IBA
03/2014

Therapy/Procedure

11Therapeutics
04/2021 - 03/2012
3Critical Care (Surgical Intensive Care)
04/2021 - 01/2020
2Extracorporeal Membrane Oxygenation
04/2021 - 01/2019
2Patient Readmission
05/2020 - 11/2017
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2020 - 03/2012
1Aftercare (After-Treatment)
10/2019
1Artificial Respiration (Mechanical Ventilation)
01/2019
1Subcutaneous Injections
09/2017